33708194|t|Long-Term Liver Expression of an Apolipoprotein A-I Mimetic Peptide Attenuates Interferon-Alpha-Induced Inflammation and Promotes Antiviral Activity.
33708194|a|Apolipoprotein A-I mimetic peptides are amphipathic alpha-helix peptides that display similar functions to apolipoprotein A-I. Preclinical and clinical studies have demonstrated the safety and efficacy of apolipoprotein A-I mimetic peptides in multiple indications associated with inflammatory processes. In this study, we evaluated the effect of the long-term expression of L37pA in the liver by an adeno-associated virus (AAV-L37pA) on the expression of an adeno-associated virus encoding interferon-alpha (AAV-IFNalpha). Long-term IFNalpha expression in the liver leads to lethal hematological toxicity one month after AAV administration. Concomitant administration of AAV-L37pA prevented the lethal toxicity since the IFNalpha expression was reduced one month after AAV administration. To identify the mechanism of action of L37pA, a genomic and proteomic analysis was performed 15 days after AAV administration when a similar level of IFNalpha and interferon-stimulated genes were observed in mice treated with AAV-IFNalpha alone and in mice treated with AAV-IFNalpha and AAV-L37pA. The coexpression of the apolipoprotein A-I mimetic peptide L37pA with IFNalpha modulated the gene expression program of IFNalpha, inducing a significant reduction in inflammatory pathways affecting pathogen-associated molecular patterns receptor, dendritic cells, NK cells and Th1 immune response. The proteomic analysis confirmed the impact of the L37pA activity on several inflammatory pathways and indicated an activation of LXR/RXR and PPPARalpha/gamma nuclear receptors. Thus, long-term expression of L37pA induces an anti-inflammatory effect in the liver that allows silencing of IFNalpha expression mediated by an adeno-associated virus.
33708194	33	51	Apolipoprotein A-I	Gene	335
33708194	79	95	Interferon-Alpha	Gene	
33708194	104	116	Inflammation	Disease	MESH:D007249
33708194	150	168	Apolipoprotein A-I	Gene	11806
33708194	257	276	apolipoprotein A-I.	Gene	11806
33708194	355	373	apolipoprotein A-I	Gene	11806
33708194	431	443	inflammatory	Disease	MESH:D007249
33708194	525	530	L37pA	Gene	
33708194	550	572	adeno-associated virus	Species	272636
33708194	574	577	AAV	Species	
33708194	578	583	L37pA	Gene	
33708194	609	631	adeno-associated virus	Species	272636
33708194	641	657	interferon-alpha	Gene	
33708194	659	662	AAV	Species	
33708194	663	671	IFNalpha	Gene	3439
33708194	684	692	IFNalpha	Gene	111654
33708194	733	755	hematological toxicity	Disease	MESH:D006402
33708194	772	775	AAV	Species	
33708194	822	825	AAV	Species	
33708194	826	831	L37pA	Gene	
33708194	853	861	toxicity	Disease	MESH:D064420
33708194	872	880	IFNalpha	Gene	3439
33708194	920	923	AAV	Species	
33708194	979	984	L37pA	Gene	
33708194	1047	1050	AAV	Species	
33708194	1090	1098	IFNalpha	Gene	111654
33708194	1148	1152	mice	Species	10090
33708194	1166	1169	AAV	Species	
33708194	1170	1178	IFNalpha	Gene	111654
33708194	1192	1196	mice	Species	10090
33708194	1210	1213	AAV	Species	
33708194	1214	1222	IFNalpha	Gene	111654
33708194	1227	1230	AAV	Species	
33708194	1231	1237	L37pA.	Gene	
33708194	1262	1280	apolipoprotein A-I	Gene	11806
33708194	1297	1302	L37pA	Chemical	-
33708194	1308	1316	IFNalpha	Gene	111654
33708194	1358	1366	IFNalpha	Gene	111654
33708194	1404	1416	inflammatory	Disease	MESH:D007249
33708194	1587	1592	L37pA	Gene	
33708194	1613	1625	inflammatory	Disease	MESH:D007249
33708194	1666	1669	LXR	Gene	22259
33708194	1744	1749	L37pA	Gene	
33708194	1766	1778	inflammatory	Disease	MESH:D007249
33708194	1824	1832	IFNalpha	Gene	111654
33708194	1859	1881	adeno-associated virus	Species	272636
33708194	Association	MESH:D007249	335
33708194	Association	MESH:D007249	111654
33708194	Positive_Correlation	MESH:D006402	111654

